Purine metabolism, inosine-adenosine-guanosine-nucleoside hydrolase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005777 | peroxisome | 6 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0020015 | glycosome | 7 | 1 |
GO:0042579 | microbody | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I4Y9
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:0006152 | purine nucleoside catabolic process | 6 | 1 |
GO:0006166 | purine ribonucleoside salvage | 5 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009116 | nucleoside metabolic process | 4 | 1 |
GO:0009119 | ribonucleoside metabolic process | 5 | 1 |
GO:0009163 | nucleoside biosynthetic process | 5 | 1 |
GO:0009164 | nucleoside catabolic process | 5 | 1 |
GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
GO:0019439 | aromatic compound catabolic process | 4 | 1 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 4 | 1 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 1 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 1 |
GO:0034656 | nucleobase-containing small molecule catabolic process | 4 | 1 |
GO:0042278 | purine nucleoside metabolic process | 5 | 1 |
GO:0042451 | purine nucleoside biosynthetic process | 6 | 1 |
GO:0042455 | ribonucleoside biosynthetic process | 6 | 1 |
GO:0043094 | cellular metabolic compound salvage | 3 | 1 |
GO:0043101 | purine-containing compound salvage | 4 | 1 |
GO:0043174 | nucleoside salvage | 4 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044282 | small molecule catabolic process | 3 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046128 | purine ribonucleoside metabolic process | 6 | 1 |
GO:0046129 | purine ribonucleoside biosynthetic process | 7 | 1 |
GO:0046700 | heterocycle catabolic process | 4 | 1 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 1 |
GO:0072521 | purine-containing compound metabolic process | 4 | 1 |
GO:0072522 | purine-containing compound biosynthetic process | 5 | 1 |
GO:0072523 | purine-containing compound catabolic process | 5 | 1 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 1 |
GO:1901136 | carbohydrate derivative catabolic process | 4 | 1 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 1 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
GO:1901657 | glycosyl compound metabolic process | 4 | 1 |
GO:1901658 | glycosyl compound catabolic process | 5 | 1 |
GO:1901659 | glycosyl compound biosynthetic process | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008477 | purine nucleosidase activity | 5 | 7 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016798 | hydrolase activity, acting on glycosyl bonds | 3 | 12 |
GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds | 4 | 12 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 273 | 275 | PF00675 | 0.219 |
CLV_NRD_NRD_1 | 298 | 300 | PF00675 | 0.338 |
CLV_PCSK_KEX2_1 | 273 | 275 | PF00082 | 0.390 |
CLV_PCSK_KEX2_1 | 298 | 300 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 197 | 201 | PF00082 | 0.238 |
CLV_PCSK_SKI1_1 | 207 | 211 | PF00082 | 0.260 |
CLV_PCSK_SKI1_1 | 233 | 237 | PF00082 | 0.281 |
CLV_PCSK_SKI1_1 | 298 | 302 | PF00082 | 0.258 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.306 |
DOC_CYCLIN_RxL_1 | 227 | 237 | PF00134 | 0.481 |
DOC_MAPK_DCC_7 | 89 | 99 | PF00069 | 0.458 |
DOC_PP1_RVXF_1 | 204 | 211 | PF00149 | 0.450 |
DOC_PP4_FxxP_1 | 190 | 193 | PF00568 | 0.517 |
DOC_USP7_MATH_1 | 219 | 223 | PF00917 | 0.445 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.560 |
DOC_USP7_MATH_1 | 70 | 74 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.501 |
DOC_USP7_UBL2_3 | 71 | 75 | PF12436 | 0.497 |
DOC_WW_Pin1_4 | 126 | 131 | PF00397 | 0.469 |
LIG_14-3-3_CanoR_1 | 85 | 91 | PF00244 | 0.473 |
LIG_APCC_ABBAyCdc20_2 | 172 | 178 | PF00400 | 0.481 |
LIG_deltaCOP1_diTrp_1 | 186 | 191 | PF00928 | 0.434 |
LIG_deltaCOP1_diTrp_1 | 83 | 86 | PF00928 | 0.501 |
LIG_EH_1 | 77 | 81 | PF12763 | 0.458 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.465 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.439 |
LIG_FHA_2 | 246 | 252 | PF00498 | 0.445 |
LIG_FHA_2 | 313 | 319 | PF00498 | 0.533 |
LIG_FHA_2 | 36 | 42 | PF00498 | 0.445 |
LIG_HCF-1_HBM_1 | 307 | 310 | PF13415 | 0.397 |
LIG_LIR_Gen_1 | 184 | 195 | PF02991 | 0.538 |
LIG_LIR_Gen_1 | 248 | 255 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 184 | 190 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 248 | 253 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 318 | 324 | PF02991 | 0.355 |
LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.458 |
LIG_NRBOX | 19 | 25 | PF00104 | 0.451 |
LIG_Pex14_2 | 80 | 84 | PF04695 | 0.434 |
LIG_SH2_CRK | 321 | 325 | PF00017 | 0.391 |
LIG_SH2_STAP1 | 260 | 264 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 310 | 313 | PF00017 | 0.501 |
LIG_SH3_3 | 134 | 140 | PF00018 | 0.445 |
LIG_SH3_3 | 94 | 100 | PF00018 | 0.525 |
LIG_SUMO_SIM_par_1 | 4 | 9 | PF11976 | 0.305 |
LIG_TYR_ITIM | 319 | 324 | PF00017 | 0.290 |
MOD_CDC14_SPxK_1 | 129 | 132 | PF00782 | 0.472 |
MOD_CDK_SPxK_1 | 126 | 132 | PF00069 | 0.472 |
MOD_CK1_1 | 211 | 217 | PF00069 | 0.458 |
MOD_CK2_1 | 125 | 131 | PF00069 | 0.569 |
MOD_CK2_1 | 245 | 251 | PF00069 | 0.445 |
MOD_GlcNHglycan | 182 | 186 | PF01048 | 0.310 |
MOD_GlcNHglycan | 241 | 244 | PF01048 | 0.301 |
MOD_GlcNHglycan | 326 | 329 | PF01048 | 0.437 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.301 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.288 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.459 |
MOD_GSK3_1 | 208 | 215 | PF00069 | 0.434 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.522 |
MOD_LATS_1 | 59 | 65 | PF00433 | 0.456 |
MOD_N-GLC_1 | 48 | 53 | PF02516 | 0.214 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.576 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.451 |
MOD_NEK2_1 | 239 | 244 | PF00069 | 0.453 |
MOD_NEK2_1 | 306 | 311 | PF00069 | 0.482 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.460 |
MOD_NEK2_2 | 70 | 75 | PF00069 | 0.458 |
MOD_OFUCOSY | 136 | 143 | PF10250 | 0.338 |
MOD_PIKK_1 | 234 | 240 | PF00454 | 0.445 |
MOD_PKA_2 | 253 | 259 | PF00069 | 0.397 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.473 |
MOD_Plk_1 | 306 | 312 | PF00069 | 0.397 |
MOD_Plk_4 | 195 | 201 | PF00069 | 0.538 |
MOD_Plk_4 | 306 | 312 | PF00069 | 0.468 |
MOD_ProDKin_1 | 126 | 132 | PF00069 | 0.469 |
TRG_DiLeu_BaEn_1 | 112 | 117 | PF01217 | 0.528 |
TRG_ENDOCYTIC_2 | 321 | 324 | PF00928 | 0.358 |
TRG_ER_diArg_1 | 273 | 275 | PF00400 | 0.414 |
TRG_Pf-PMV_PEXEL_1 | 273 | 277 | PF00026 | 0.319 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDW1 | Leptomonas seymouri | 77% | 100% |
A0A0S4KHF3 | Bodo saltans | 49% | 91% |
A0A1X0P908 | Trypanosomatidae | 64% | 100% |
A0A3S7X2U5 | Leishmania donovani | 100% | 100% |
A0A422NEX0 | Trypanosoma rangeli | 62% | 100% |
A4H7H4 | Leishmania braziliensis | 26% | 95% |
A4HHT6 | Leishmania braziliensis | 86% | 100% |
A8AJF8 | Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696) | 26% | 100% |
B4SYM0 | Salmonella newport (strain SL254) | 27% | 100% |
C9ZKK0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9AEE2 | Leishmania major | 93% | 100% |
E9ALE4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q0HEZ4 | Shewanella sp. (strain MR-4) | 27% | 100% |
Q0HZ05 | Shewanella sp. (strain MR-7) | 26% | 100% |
Q10314 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 100% |
Q8LAC4 | Arabidopsis thaliana | 28% | 100% |
Q9P6J4 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 23% | 100% |
V5BSM6 | Trypanosoma cruzi | 62% | 100% |